English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Apr 25, 2024

"My Future Depends on It:" Local Teacher Raises Nearly $95,000 for Lung Cancer Research

+ Pharmaceuticals
Patient Daily | Apr 25, 2024

Labor and delivery nurse overcomes cancer and heart failure

+ Pharmaceuticals
Patient Daily | Apr 24, 2024

American Lung Association Report: Idaho Struggles with Short-Term Particle Pollution in “State of the Air” Report Findings

+ Pharmaceuticals
Patient Daily | Apr 24, 2024

American Lung Association Report: Alaska Receives Mixed Marks for Short-Term Particle Pollution

+ Pharmaceuticals
Patient Daily | Apr 24, 2024

Scientists Unveil Genetics Behind Development of Gliding

+ Pharmaceuticals
Patient Daily | Apr 24, 2024

Bangor, ME Metro Area Ranked One of Cleanest Cities in the U.S., According to the 25th Annual ‘State of the Air’ Report

+ Pharmaceuticals
Patient Daily | Apr 24, 2024

Washington struggles with particle pollution: American Lung Association Report

+ Pharmaceuticals
Patient Daily | Apr 24, 2024

American Lung Association Report: Utah Receives Poor Grades for Ozone and Particle Pollution

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes

  • « First
  • «
  • …
  • 268
  • 269
  • 270
  • 271
  • 272
  • 273
  • 274
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily